Recent research indicates that semaglutide, a drug used for diabetes and weight loss, could effectively…
Browsing: Semaglutide
Semaglutide is a medication primarily used to treat type 2 diabetes and obesity. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the naturally occurring hormone GLP-1 to increase insulin secretion, reduce appetite, and slow down digestion. This helps in better blood sugar control and weight loss. Semaglutide is available in injectable forms and as an oral tablet, and it has been shown in clinical trials to be highly effective in improving glycemic control and aiding significant weight loss, making it a valuable option for managing these conditions.
A phase 3 clinical trial has found that the injectable prescription medication tirzepatide, in combination…
They’re being hailed as an effective way to lose weight, but diabetes drugs like Ozempic…
Researchers urge for clearer communication to aid the general public and policymakers in gaining a…
The medication Semaglutide, also known by brand names like Ozempic, has been approved to treat…
Nearly Half of Adolescents Using Semaglutide in Trial Dropped Below the Clinical Cut-Off for Obesity…
Change in cost may improve affordability and access to treatment. New research shows that…
A new study published in the New England Journal of Medicine and presented at Obesity…
Tirzepatide, a new diabetes drug administered weekly through injection, helped those with type 2 diabetes…
The risk of type 2 diabetes is reduced by more than half by weekly injections…
Drugs that promise to help people lose weight have had a checkered past, such as…
Novel obesity treatments such as modulation of the gut microbiome and gene therapy are underutilized…
Weight loss of 15% or more should become a central focus of managing type 2…
Females and those with lower body weight have better results. New research presented at this…
Findings suggest drug has the potential to reduce the risk of heart disease, diabetes, and…
One third (35%) of people who took a new drug for treating obesity lost more…